-
Mashup Score: 0An Unexpected Lesson to Live Intentionally - 20 hour(s) ago
In the latest installment of her leadership series, Barbara Schmidtman delves into the unexpected gift that can come from illness: stillness and time for reflection.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Treatment for Relapsed or Refractory Multiple Myeloma: Care Team Perspectives on a Bispecific Antibody - 3 day(s) ago
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, Dr Noa Biran, Susan Kumka and Maribel Pereiras are paid consultants for Johnson & Johnson and must present information in accordance with US Food & Drug Administration (FDA) requirements applicable to Johnson & Johnson. Multiple myeloma remains incurable, and most patients will inevitably relapse and cycle through multiple lines of therapy.² The treatment landscape of relapsed or refractory multiple
Source: journals.accc-cancer.orgCategories: General Medicine News, NursingTweet-
Read the latest Oncology Issues to learn how a multiple myeloma treatment team integrated a bispecific antibody therapy in the community setting, enabling patients to receive high-quality care closer to home: https://t.co/BaTQNv7qGu. https://t.co/ILIkM93lAV
-
-
Mashup Score: 0Bringing Cancer Research to the Community: Strategic Approaches to Representative Oncology Clinical Trial Design - 5 day(s) ago
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, The oncology clinical research landscape is undergoing trans- formative changes, marked by patient-centered approaches and operational efficiency in the community setting. New strategies for clinical trial design seek to ensure that study populations reflect the true heterogeneity of all patients affected by cancer, thereby improving the generalizability and application of clinical research findings.
Source: journals.accc-cancer.orgCategories: General Medicine News, NursingTweet-
ACORI hosted the Community Inclusive Clinical Trial Design Summit in Fall 2024 to bring key stakeholders together to discuss ways to strategically reduce barriers to clinical trial participation. Read the highlights in this month’s Oncology Issues: https://t.co/OYPYjxccLl! https://t.co/UUmUGYg5GU
-
-
Mashup Score: 1Addressing Social Drivers of Health: A Quality Improvement Approach to Developing Oncology-Specific Screening Tools - 9 day(s) ago
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, Advancements in cancer diagnostics and precision medicine have ushered in significant breakthroughs for patients diagnosed with cancer. However, the conditions in which people live, work, and play—social determinants of health (SDOH), also referred to as social drivers of health—can be just as critical to an individual’s health outcome as factors like baseline health status, disease characteristics, and
Source: journals.accc-cancer.orgCategories: General Medicine News, NursingTweet-
To address the inequalities that result from social drivers of health, ACCC developed an oncology-specific screening tool and resource library to better equip multidisciplinary cancer care teams with the skills to identify and address barriers to care. https://t.co/mzQxbP6FtR https://t.co/pJFPfYdGem
-
-
Mashup Score: 0
This first installment in the ACCCBuzz Blog 2025 Innovator Award Winners series highlights Penn Medicine Princeton Health, Princeton Cancer Center, and the program’s strategy to implement a structured, scalable geriatric oncology program.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
Penn Medicine Princeton Health, 1 of 6 ACCC 2025 Innovators, is addressing a critical gap in cancer care for older adults through its implementation of a structured, scalable geriatric oncology program. Learn more on the ACCCBuzz blog: https://t.co/6oFp52B1xt. @PrincetonHealth https://t.co/UiLvcoEnit
-
-
Mashup Score: 0
As we observe World Ovarian Cancer Day in 2025, health care professionals are encouraged to recognize how precision oncology is reshaping treatment paradigms and presenting new opportunities to personalize care and improve survival outcomes.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
On #WorldOvarianCancerDay, ACCC encourages health care professionals to recognize how precision oncology is reshaping treatment paradigms and presenting new opportunities to personalize care and improve survival outcomes. Read our blog for more: https://t.co/ICyp8wZjpR. https://t.co/XdEvjiuAHu
-
-
Mashup Score: 0Bridging Oncology and Dermatology: Integrating Dermatologic Toxicity Management Into Routine Cancer Care - 10 day(s) ago
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, An estimated 50% o f patients with cancer experience disruptions in treatment due to dermatologic toxicity. Anticancer treatment strategies have grown in number and complexity in recent decades, as have the toxicity profiles associated with these therapeutic agents. The increasing use of novel cancer therapies—including molecular targeted therapies, immunotherapies, hormonal therapies, and combinations
Source: journals.accc-cancer.orgCategories: General Medicine News, NursingTweet-
Discover how integrating dermatologic expertise into oncology can prevent treatment disruptions and improve patient outcomes in the latest installment of Oncology Issues: https://t.co/ykPGGKdlTC. https://t.co/bBdoZFkdco
-
-
Mashup Score: 0
In support of the need for more advanced Digital Health Technologies, ACCC partnered with DiMe to create comprehensive resources that support the development of trustworthy CRS de-risking products.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
To support the need for more advanced Digital Health Technologies, ACCC partnered with the Digital Medicine Society (DiMe) to create comprehensive resources that support the development of trustworthy #CRS de-risking products. Learn more: https://t.co/eUlYwhmo26. https://t.co/TlPyjH2ngJ
-
-
Mashup Score: 0
April is Esophageal Cancer Awareness Month, a time for increasing public awareness about the importance of early detection and facilitating emerging therapies for patients diagnosed with esophageal cancer.
Source: www.accc-cancer.orgCategories: General Medicine News, NursingTweet-
Learn how improved #Screening practices and the emerging landscape of #PrecisionMedicine are influencing outcomes for patients with #EsophagealCancer in our recent blog: https://t.co/LDh2seplLu. https://t.co/kCaNwPwrVU
-
-
Mashup Score: 0Adverse Event Management for CDK Inhibitors in Hormone Receptor–Positive Breast Cancer - 12 day(s) ago
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume
Source: journals.accc-cancer.orgCategories: General Medicine News, NursingTweet-
This month’s Oncology Issues features an overview of 3 CDK4/6 inhibitors recently approved for use in patients with breast cancer, including common adverse effects and tips to promote patient adherence. Read more: https://t.co/HixNgi8KU4. https://t.co/Hqlp9Kytxl
-
Read the latest blog from Barbara Schmidtman, PhD, where she reflects on how living with a disease like cancer—or caring for those who do—reminds readers of the importance of living intentionally and the value of each day: https://t.co/RXeWkf8z2A. https://t.co/09AWHFLSvi